Gene Change Leadership Change at GeneOne

GeneOne is facing some significant challenges in its leadership individuals and structure as the company heads towards its IPO on a fairly accelerated schedule. The company has been immensely successful since its founding, largely due to the individual talents of the executives that helped to found or were brought into the company, but none of these team members have any experience whatsoever with IPOs, meaning a change in leadership will be necessary in order to effectively guide GeneOne through its next phase of growth (BrainMass 2010). In addition, not all team members are on board with the strategy that has been discussed and decided upon for bringing off the IPO successfully, and similarly not all of GeneOne's leaders are especially happy with the IPO itself or what it represents.

There are...

One of the major choices that needs to be made is wither the current CTO and lead scientific innovator at the company, Terri Robertson, should remain. Though she has been an invaluable asset to the company and is in fact responsible for the technological breakthrough that led to the company's establishment in the first place, she has also made it clear that she is not fully committed to an established business timeline for scientific developments. A leader that is not on board with the overall changes and trajectory of their organization can be a tremendous liability, not only hindering operations but affecting morale and potentially alienating a huge an integral segment of the…